These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12474874)

  • 1. Interpretation of analysis.
    Heller JG
    Can J Clin Pharmacol; 2002; 9(3):129, 153; author reply 153. PubMed ID: 12474874
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacoeconomic evaluation of clozapine in treatment-resistant schizophrenia: a cost-utility analysis.
    Oh PI; Iskedjian M; Addis A; Lanctôt K; Einarson TR
    Can J Clin Pharmacol; 2001; 8(4):199-206. PubMed ID: 11743592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine and hospitalization.
    Rosenheck R; Charney D; Cramer J
    Psychiatr Serv; 1999 Jan; 50(1):114-6. PubMed ID: 9890595
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of atypical antipsychotics in chronic schizophrenia.
    Amin S
    Hosp Med; 1999 Jun; 60(6):410-3. PubMed ID: 10492711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should clozapine continue to be restricted to third-line status for schizophrenia?: a decision-analytic model.
    Wang PS; Ganz DA; Benner JS; Glynn RJ; Avorn J
    J Ment Health Policy Econ; 2004 Jun; 7(2):77-85. PubMed ID: 15208468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The impact of antipsychotic medication on the incidence and the costs of inpatient treatment in people with schizophrenia: results from a prospective observational study].
    Kilian R; Angermeyer MC
    Psychiatr Prax; 2004 Apr; 31(3):138-46. PubMed ID: 15042477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory schizophrenia: what works pharmacologically?
    Sousa S
    J Psychosoc Nurs Ment Health Serv; 1999 Feb; 37(2):19-23. PubMed ID: 10023603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mental health. Special agents.
    Bryan J
    Health Serv J; 1999 Jan; 109(5639):suppl 4-6. PubMed ID: 10345647
    [No Abstract]   [Full Text] [Related]  

  • 9. Generic replacement of clozapine: a simple decision model from a Canadian perspective.
    Layton S; Barbeau M
    Curr Med Res Opin; 2004 Apr; 20(4):453-9. PubMed ID: 15119982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expensive but nevertheless cost effect? Pharmacoeconomics of atypical neuroleptics].
    Laux G; Günther W
    Pharm Unserer Zeit; 2002; 31(6):572-6. PubMed ID: 12481515
    [No Abstract]   [Full Text] [Related]  

  • 11. The treatment of psychosis: resetting the drug cost 'thermostat'.
    Reid WH
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():166-8. PubMed ID: 7961565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of antipsychotic drugs. A commentary on: Cost Utility Of The Latest Antipsychotic Drugs In Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE).
    Lieberman JA
    Arch Gen Psychiatry; 2006 Oct; 63(10):1069-72. PubMed ID: 17015808
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clozapine treatment of patients with schizophrenia. Great improvements with regard to symptoms and social life].
    Jonsson D; Zethraeus N; Mansfield M; Wålinder J
    Lakartidningen; 1993 Apr; 90(16):1564-6. PubMed ID: 8483355
    [No Abstract]   [Full Text] [Related]  

  • 14. The cost-effectiveness of clozapine: a controlled, population-based, mirror-image study.
    Hayhurst KP; Brown P; Lewis SW
    J Psychopharmacol; 2002 Jun; 16(2):169-75. PubMed ID: 12095076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cost-effectiveness of Antipsychotics in the Maintenance Treatment of Schizophrenia in Colombia].
    Quitian Reyes H; Arciniegas Barrera JA; Bohórquez Peñaranda A; Gómez Restrepo C
    Rev Colomb Psiquiatr; 2016; 45(2):67-74. PubMed ID: 27132755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost analysis of treating schizophrenia with amisulpride: naturalistic mirror image study.
    Surguladze S; Patel A; Kerwin RW; Knapp M; Travis MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):517-22. PubMed ID: 15866352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why don't we use clozapine more often?
    Sajatovic M
    Psychiatr Serv; 2014 Feb; 65(2):135. PubMed ID: 24492895
    [No Abstract]   [Full Text] [Related]  

  • 18. From darkness with courage...
    Aldridge R
    Nurs N Z; 1997 Oct; 3(9):21-2. PubMed ID: 9386466
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescribing. Switching schizophrenia treatments.
    Marven M
    Health Serv J; 2005 Mar; 115(5948):suppl 12. PubMed ID: 15825666
    [No Abstract]   [Full Text] [Related]  

  • 20. The Business Case for Expanded Clozapine Utilization.
    Gören JL; Rose AJ; Smith EG; Ney JP
    Psychiatr Serv; 2016 Nov; 67(11):1197-1205. PubMed ID: 27301766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.